| 000 | 00907 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250517072126.0 | ||
| 264 | 0 | _c20160906 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1873-4995 | ||
| 024 | 7 |
_a10.1016/j.jconrel.2015.12.026 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPark, Kinam | |
| 245 | 0 | 0 |
_aAn integrated assessment of PEGylated liposomal doxorubicin products. _h[electronic resource] |
| 260 |
_bJournal of controlled release : official journal of the Controlled Release Society _cJan 2016 |
||
| 300 |
_a71 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aDoxorubicin |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPolyethylene Glycols |
| 773 | 0 |
_tJournal of controlled release : official journal of the Controlled Release Society _gvol. 221 _gp. 71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jconrel.2015.12.026 _zAvailable from publisher's website |
| 999 |
_c25588664 _d25588664 |
||